ArticleDisease markers2015

Polymorphisms in C-reactive protein and Glypican-5 are associated with lung cancer risk and Gartrokine-1 influences Cisplatin-based chemotherapy response in a Chinese Han population.

Shuo Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.